正业生物股价波动明显，成交额激增230.03%

Core Viewpoint - Zhengye Biological (ZYBT.US) focuses on the research, production, and sales of veterinary vaccines, primarily generating revenue from pig and poultry vaccines [1] Group 1: Company Overview - Zhengye Biological specializes in veterinary vaccine development, production, and sales [1] - The company's main revenue sources are pig vaccines and poultry vaccines [1] Group 2: Recent Performance - As of January 2026, the company's stock price and trading volume have experienced fluctuations [1] - On January 9, 2026, the trading volume surged by 230.03% [1] - No significant planned events such as new product launches, clinical trial progress, or capital operations have been mentioned in the available information [1]